Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin

E. Reshef, James Segars, G. A. Hill, D. D. Pridham, M. A. Yussman, A. C. Wentz

Research output: Contribution to journalArticle

Abstract

The incidence of abnormal endometrial histology in patients undergoing human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) treatment during cycles of in vitro fertilization (IVF) or gamete intrafallopian transfer has been reported to be 52% to 91%. The incidence of endometrial inadequacy, as judged by a single late luteal endometrial biopsy, has not been studied in hMG/hCG non-IVF cycles. In the current study, 30 patients (30 cycles) undergoing hMG/hCG treatment were evaluated by an endometrial biopsy. The incidence of endometrial inadequacy was found to be 27%. No preovulatory predictors for endometrial inadequacy could be identified. Therefore, luteal support for patients undergoing non-IVF hMG/hCG cycles should be considered.

Original languageEnglish (US)
Pages (from-to)1012-1016
Number of pages5
JournalFertility and Sterility
Volume54
Issue number6
StatePublished - 1990
Externally publishedYes

Fingerprint

Menotropins
Chorionic Gonadotropin
Corpus Luteum
Fertilization
Incidence
Gamete Intrafallopian Transfer
Biopsy
Fertilization in Vitro
Therapeutics
Histology

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Reshef, E., Segars, J., Hill, G. A., Pridham, D. D., Yussman, M. A., & Wentz, A. C. (1990). Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin. Fertility and Sterility, 54(6), 1012-1016.

Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin. / Reshef, E.; Segars, James; Hill, G. A.; Pridham, D. D.; Yussman, M. A.; Wentz, A. C.

In: Fertility and Sterility, Vol. 54, No. 6, 1990, p. 1012-1016.

Research output: Contribution to journalArticle

Reshef, E, Segars, J, Hill, GA, Pridham, DD, Yussman, MA & Wentz, AC 1990, 'Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin', Fertility and Sterility, vol. 54, no. 6, pp. 1012-1016.
Reshef, E. ; Segars, James ; Hill, G. A. ; Pridham, D. D. ; Yussman, M. A. ; Wentz, A. C. / Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin. In: Fertility and Sterility. 1990 ; Vol. 54, No. 6. pp. 1012-1016.
@article{ef3fca6e3d3c4cedb2891d9c2138faca,
title = "Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin",
abstract = "The incidence of abnormal endometrial histology in patients undergoing human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) treatment during cycles of in vitro fertilization (IVF) or gamete intrafallopian transfer has been reported to be 52{\%} to 91{\%}. The incidence of endometrial inadequacy, as judged by a single late luteal endometrial biopsy, has not been studied in hMG/hCG non-IVF cycles. In the current study, 30 patients (30 cycles) undergoing hMG/hCG treatment were evaluated by an endometrial biopsy. The incidence of endometrial inadequacy was found to be 27{\%}. No preovulatory predictors for endometrial inadequacy could be identified. Therefore, luteal support for patients undergoing non-IVF hMG/hCG cycles should be considered.",
author = "E. Reshef and James Segars and Hill, {G. A.} and Pridham, {D. D.} and Yussman, {M. A.} and Wentz, {A. C.}",
year = "1990",
language = "English (US)",
volume = "54",
pages = "1012--1016",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Endometrial inadequacy after treatment with human menopausal gonadotropin/human chorionic gonadotropin

AU - Reshef, E.

AU - Segars, James

AU - Hill, G. A.

AU - Pridham, D. D.

AU - Yussman, M. A.

AU - Wentz, A. C.

PY - 1990

Y1 - 1990

N2 - The incidence of abnormal endometrial histology in patients undergoing human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) treatment during cycles of in vitro fertilization (IVF) or gamete intrafallopian transfer has been reported to be 52% to 91%. The incidence of endometrial inadequacy, as judged by a single late luteal endometrial biopsy, has not been studied in hMG/hCG non-IVF cycles. In the current study, 30 patients (30 cycles) undergoing hMG/hCG treatment were evaluated by an endometrial biopsy. The incidence of endometrial inadequacy was found to be 27%. No preovulatory predictors for endometrial inadequacy could be identified. Therefore, luteal support for patients undergoing non-IVF hMG/hCG cycles should be considered.

AB - The incidence of abnormal endometrial histology in patients undergoing human menopausal gonadotropin/human chorionic gonadotropin (hMG/hCG) treatment during cycles of in vitro fertilization (IVF) or gamete intrafallopian transfer has been reported to be 52% to 91%. The incidence of endometrial inadequacy, as judged by a single late luteal endometrial biopsy, has not been studied in hMG/hCG non-IVF cycles. In the current study, 30 patients (30 cycles) undergoing hMG/hCG treatment were evaluated by an endometrial biopsy. The incidence of endometrial inadequacy was found to be 27%. No preovulatory predictors for endometrial inadequacy could be identified. Therefore, luteal support for patients undergoing non-IVF hMG/hCG cycles should be considered.

UR - http://www.scopus.com/inward/record.url?scp=0025604524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025604524&partnerID=8YFLogxK

M3 - Article

C2 - 2123159

AN - SCOPUS:0025604524

VL - 54

SP - 1012

EP - 1016

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -